Literature DB >> 31938803

Cardiovascular disease in patients with chronic kidney disease.

Turgay Saritas1, Jürgen Floege2.   

Abstract

Patients with chronic kidney disease (CKD) are at increased risk for kidney failure, cardiovascular disease (CVD), and death. In fact, the likelihood of dying from CVD is markedly higher than that for reaching end-stage renal disease. Evidence-based management of comorbidities such as CVD remains challenging in patients with advanced CKD, as they were usually excluded from randomized controlled trials. This review focuses on the epidemiology, risk factors, and clinical manifestations of CVD in patients with advanced CKD. Specific topics of interest include diagnostic and therapeutic challenges of heart failure, coronary artery disease, and atrial fibrillation.

Entities:  

Keywords:  Coronary artery disease; Epidemiology; Kidney failure; Renal insufficiency; Risk factors

Mesh:

Year:  2020        PMID: 31938803     DOI: 10.1007/s00059-019-04884-0

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  53 in total

1.  Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients.

Authors:  Shigeki Yamada; Hideki Ishii; Hiroshi Takahashi; Toru Aoyama; Yasuhiro Morita; Hirotake Kasuga; Keiko Kimura; Yutaka Ito; Ryo Takahashi; Takanobu Toriyama; Yoshinari Yasuda; Mutsuharu Hayashi; Hideki Kamiya; Yukio Yuzawa; Shoichi Maruyama; Seiichi Matsuo; Tatsuaki Matsubara; Toyoaki Murohara
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

2.  Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.

Authors:  Nisha Bansal; Dongjie Fan; Chi-yuan Hsu; Juan D Ordonez; Greg M Marcus; Alan S Go
Journal:  Circulation       Date:  2012-12-28       Impact factor: 29.690

Review 3.  Cardiorenal Interactions Revisited: How to Improve Heart Failure Outcomes in Patients With Chronic Kidney Disease.

Authors:  Mattia Arrigo; Pietro E Cippà; Alexandre Mebazaa
Journal:  Curr Heart Fail Rep       Date:  2018-10

Review 4.  Survival after coronary revascularization among patients with kidney disease.

Authors:  Brenda R Hemmelgarn; Danielle Southern; Bruce F Culleton; L Brent Mitchell; Merril L Knudtson; William A Ghali
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

5.  The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.

Authors:  Aimun K Ahmed; Neetha S Kamath; Mohsen El Kossi; A Meguid El Nahas
Journal:  Nephrol Dial Transplant       Date:  2009-10-10       Impact factor: 5.992

6.  Estimating the Risk of Radiocontrast-Associated Nephropathy.

Authors:  Emilee Wilhelm-Leen; Maria E Montez-Rath; Glenn Chertow
Journal:  J Am Soc Nephrol       Date:  2016-09-29       Impact factor: 10.121

7.  What should the physician do when creatinine increases after starting an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker?

Authors:  Debbie L Cohen; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-10       Impact factor: 3.738

8.  Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease.

Authors:  Yogesh N V Reddy; Masaru Obokata; Patrick G Dean; Vojtech Melenovsky; Karl A Nath; Barry A Borlaug
Journal:  Eur Heart J       Date:  2017-06-21       Impact factor: 29.983

Review 9.  Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.

Authors:  Nathan R Hill; Samuel T Fatoba; Jason L Oke; Jennifer A Hirst; Christopher A O'Callaghan; Daniel S Lasserson; F D Richard Hobbs
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

10.  Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.

Authors:  Sunil Bhandari; Natalie Ives; Elizabeth A Brettell; Marie Valente; Paul Cockwell; Peter S Topham; John G Cleland; Arif Khwaja; Meguid El Nahas
Journal:  Nephrol Dial Transplant       Date:  2015-09-30       Impact factor: 5.992

View more
  6 in total

1.  Investigation on the Association of Cardiovascular Markers with Severity of Chronic Pyelonephritis.

Authors:  O A Efremova; L A Kamyshnikova; S E Veysalov; M S Sviridova; N I Obolonkova; M A Gayvoronskaya; M Wuraola
Journal:  Arch Razi Inst       Date:  2022-02-28

2.  Network-Based Approach and IVI Methodologies, a Combined Data Investigation Identified Probable Key Genes in Cardiovascular Disease and Chronic Kidney Disease.

Authors:  Mohd Murshad Ahmed; Safia Tazyeen; Shafiul Haque; Ahmad Sulimani; Rafat Ali; Mohd Sajad; Aftab Alam; Shahnawaz Ali; Hala Abubaker Bagabir; Rania Abubaker Bagabir; Romana Ishrat
Journal:  Front Cardiovasc Med       Date:  2022-01-05

Review 3.  The Pathogenesis of End-Stage Renal Disease from the Standpoint of the Theory of General Pathological Processes of Inflammation.

Authors:  Evgenii Gusev; Liliya Solomatina; Yulia Zhuravleva; Alexey Sarapultsev
Journal:  Int J Mol Sci       Date:  2021-10-23       Impact factor: 5.923

4.  Oxone®-Mediated TEMPO-Oxidized Cellulose Nanomaterial Ultrafiltration and Dialysis Mixed-Matrix Hollow Fiber Membranes.

Authors:  John P Moore; Kristyn Robling; Cristian Romero; Keturah Kiper; Soma Shekar Dachavaram; Peter A Crooks; Jamie A Hestekin
Journal:  Polymers (Basel)       Date:  2020-06-15       Impact factor: 4.329

5.  Danegaptide Prevents TGFβ1-Induced Damage in Human Proximal Tubule Epithelial Cells of the Kidney.

Authors:  Paul E Squires; Gareth W Price; Ulrik Mouritzen; Joe A Potter; Bethany M Williams; Claire E Hills
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

6.  Apo A1/Apo B ratio and acute coronary syndrome among peritoneal dialysis patients.

Authors:  Tianlei Chen; Min Yang
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.